Wondering Why Intuitive Surgical Fell? Here's What Bears Saw

Intuitive Surgical spent much of 2026 in the headlines for FDA stapler warnings, tariff worries, and fresh competition from Johnson & Johnson's OTTAVA robot, yet the real story for many investors sat quietly in their brokerage statements. For Intuitive Surgical shareholders, the loss from the start of the year was 21.0%, including dividends. If you had been weighing a position back on 1 January 2026, how could the mix of optimism and caution already on record have framed your expectations for this outcome?

Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.

Intuitive Surgical has already moved. Pinpoint other ways to investigate the theme among 93 robotics and automation stocks.

The Two Intuitive Surgical Stories You Had To Weigh

The shares cost US$566 at the start, and Intuitive Surgical sat between two grounded stories about what came next for robotic surgery.

The bullish narrative put Fair Value at US$685, based on faster adoption of da Vinci 5, deeper digital integration in the operating room, and an upgrade cycle that could support higher system sales and recurring usage.

The bearish narrative argued for Fair Value of US$350, focusing on global healthcare cost pressure, tariff driven increases in cost of sales, and tighter reimbursement that could squeeze pricing and margins.

What The Evidence Did To The Intuitive Surgical Argument

Intuitive Surgical’s Q3 2026 report gave bulls and bears something specific to work with. Revenue reached US$3.05b, above Q3 2025’s US$2.51b, which lined up with the growth focused story. Net income excluding one off items moved the other way and net margin dropped from 28.1% to 17.1% after the proposed US$450m settlement, which backed the cautious case on profitability. Overall, the evidence cut both ways.

The hinge assumption was not just procedure growth; it was margin resilience. When you look at another robotics stock, track whether higher sales are matched by stable or improving net margin in the filings rather than only by talk of volume or new platforms.

What Intuitive Surgical’s Drop Already Prices In

Intuitive Surgical now trades at US$444, leaving shareholders with a 21.0% loss from the start of the year. The selected Narrative’s Fair Value sits above the current price, based on a detailed view of da Vinci systems, procedure volumes, and the surrounding digital tools.

That higher figure depends on recurring instruments, services, and software tied to the da Vinci ecosystem remaining strong enough to support the assumed profitability and cash generation.

"A growing installed base is good, but the recurring revenue makes the difference. Today, 9,539 da Vinci systems are installed worldwide, with an annual growth rate of 15.1%. Each year, these systems perform approximately 2.2 million procedures, a number that has been growing at a rate of 22.2% per year."

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all

Which Company Could Surprise You Next?

This company's disappointment is already part of the story. Your next idea could come from looking where the price and the possibilities still seem far apart. Here are three companies priced below our estimates.

• Company 1 - 43% below our estimate - converts a record mechanical and electrical backlog into data center buildouts and services.
• Company 2 - 46% below our estimate - turns a substantial construction backlog and multiple mega-projects into cash to manage disputes.
• Company 3 - 34% below our estimate - ramps high horsepower engine capacity to serve long term data center power needs.

That is three of the list. See every one of the 26 undervalued companies on it →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com